These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24249805)

  • 21. Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists.
    Merker VL; Knight P; Radtke HB; Yohay K; Ullrich NJ; Plotkin SR; Jordan JT
    Orphanet J Rare Dis; 2022 Feb; 17(1):44. PubMed ID: 35144646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofibromatosis Clinical Trial Consortium.
    Packer RJ; Fisher MJ; Cutter G; Cole-Plourde K; Korf BR
    J Child Neurol; 2018 Jan; 33(1):82-91. PubMed ID: 29246097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
    Tamura R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.
    Seidlin M; Holzman R; Knight P; Korf B; Rangel Miller V; Viskochil D; Bakker A;
    PLoS One; 2017; 12(6):e0178639. PubMed ID: 28644838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibromatosis as a gateway to better treatment for a variety of malignancies.
    Bakker AC; La Rosa S; Sherman LS; Knight P; Lee H; Pancza P; Nievo M
    Prog Neurobiol; 2017 May; 152():149-165. PubMed ID: 26854064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Status and Recommendations for Incorporating Biomarkers for Cutaneous Neurofibromas Into Clinical Research.
    Wallis D; Stemmer-Rachamimov A; Adsit S; Korf B; Pichard D; Blakeley J; Sarin KY;
    Neurology; 2021 Aug; 97(7 Suppl 1):S42-S49. PubMed ID: 34230199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature.
    Vranceanu AM; Merker VL; Park E; Plotkin SR
    J Neurooncol; 2013 Sep; 114(3):257-62. PubMed ID: 23817811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of mind-body treatment interventions on quality of life in neurofibromatosis patients: A systematic review and meta-analysis.
    Wei G; Farooq J; Kumar A
    Dermatol Ther; 2021 Jan; 34(1):e14613. PubMed ID: 33258517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.
    Rauen KA; Alsaegh A; Ben-Shachar S; Berman Y; Blakeley J; Cordeiro I; Elgersma Y; Evans DG; Fisher MJ; Frayling IM; George J; Huson SM; Kerr B; Khire U; Korf B; Legius E; Messiaen L; van Minkelen R; Nampoothiri S; Ngeow J; Parada LF; Phadke S; Pillai A; Plotkin SR; Puri R; Raji A; Ramesh V; Ratner N; Shankar SP; Sharda S; Tambe A; Vikkula M; Widemann BC; Wolkenstein P; Upadhyaya M
    Am J Med Genet A; 2019 Jun; 179(6):1091-1097. PubMed ID: 30908877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofibromatoses: part 1 - diagnosis and differential diagnosis.
    Rodrigues LO; Batista PB; Goloni-Bertollo EM; de Souza-Costa D; Eliam L; Eliam M; Cunha KS; Darrigo-Junior LG; Ferraz-Filho JR; Geller M; Gianordoli-Nascimento IF; Madeira LG; Malloy-Diniz LF; Mendes HM; de Miranda DM; Pavarino EC; Baptista-Pereira L; Rezende NA; Rodrigues Lde O; da Silva CM; de Souza JF; de Souza ML; Stangherlin A; Valadares ER; Vidigal PV
    Arq Neuropsiquiatr; 2014 Mar; 72(3):241-50. PubMed ID: 24676443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues.
    Rauen KA; Huson SM; Burkitt-Wright E; Evans DG; Farschtschi S; Ferner RE; Gutmann DH; Hanemann CO; Kerr B; Legius E; Parada LF; Patton M; Peltonen J; Ratner N; Riccardi VM; van der Vaart T; Vikkula M; Viskochil DH; Zenker M; Upadhyaya M
    Am J Med Genet A; 2015 Jan; 167A(1):1-10. PubMed ID: 25393061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schwannomatosis: the overlooked neurofibromatosis?
    Koontz NA; Wiens AL; Agarwal A; Hingtgen CM; Emerson RE; Mosier KM
    AJR Am J Roentgenol; 2013 Jun; 200(6):W646-53. PubMed ID: 23701098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creation of an international registry to support discovery in schwannomatosis.
    Ostrow KL; Bergner AL; Blakeley J; Evans DG; Ferner R; Friedman JM; Harris GJ; Jordan JT; Korf B; Langmead S; Leschziner G; Mautner V; Merker VL; Papi L; Plotkin SR; Slopis JM; Smith MJ; Stemmer-Rachamimov A; Yohay K; Belzberg AJ
    Am J Med Genet A; 2017 Feb; 173(2):407-413. PubMed ID: 27759912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.
    Plotkin SR; Blakeley JO; Evans DG; Hanemann CO; Hulsebos TJ; Hunter-Schaedle K; Kalpana GV; Korf B; Messiaen L; Papi L; Ratner N; Sherman LS; Smith MJ; Stemmer-Rachamimov AO; Vitte J; Giovannini M
    Am J Med Genet A; 2013 Mar; 161A(3):405-16. PubMed ID: 23401320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status and recommendations for biomarkers and biobanking in neurofibromatosis.
    Hanemann CO; Blakeley JO; Nunes FP; Robertson K; Stemmer-Rachamimov A; Mautner V; Kurtz A; Ferguson M; Widemann BC; Evans DG; Ferner R; Carroll SL; Korf B; Wolkenstein P; Knight P; Plotkin SR;
    Neurology; 2016 Aug; 87(7 Suppl 1):S40-8. PubMed ID: 27527649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
    International Liaison Committee on Resuscitation
    Pediatrics; 2006 May; 117(5):e955-77. PubMed ID: 16618790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations for Measurement of Attention Outcomes in Preschoolers With Neurofibromatosis.
    Klein-Tasman BP; Lee K; Thompson HL; Janusz J; Payne JM; Pardej S; de Blank P; Kennedy T; Janke KM; Castillo AD; Walsh KS;
    Neurology; 2021 Aug; 97(7 Suppl 1):S81-S90. PubMed ID: 34230206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.